Big Gain For ImmunoGen, Inc.
Thu, Nov 30, 2023 at 07:42 PM
ImmunoGen, Inc. (IMGN:NASDAQ) soared at $29.35, representing a gain of 82.8%. On Thu, Nov 30, 2023, IMGN:NASDAQ touched a New 2-Week High of $29.35. The stock appeared on our News Catalysts scanner on Thu, Nov 30, 2023 at 05:26 PM in the 'ACQUISITION' category. From Thu, Nov 16, 2023, the stock recorded 66.67% Up Days and 50.00% Green Days
About ImmunoGen, Inc. (IMGN:NASDAQ)
Immunogen Inc is a clinical-stage biotechnology company that develops targeted anticancer therapeutics. It has developed its ADC technology to enable the creation of anticancer products.
Top 10 Gainers:
- Ampio Pharmaceuticals, Inc. (AMPE:NYSEMKT), 193.89%
- Signature Bank (SBNY:NASDAQ), 150%
- Soligenix, Inc. (SNGX:NASDAQ), 135.97%
- Incannex Healthcare Limited (IXHL:NASDAQ), 84.95%
- ImmunoGen, Inc. (IMGN:NASDAQ), 82.75%
- SeaChange International, Inc. (SEAC:NASDAQ), 74.22%
- Intelligent Bio Solutions Inc Com (INBS:NASDAQ), 61.35%
- Smart for Life Inc. (SMFL:NASDAQ), 58.55%
- NeuBase Therapeutics, Inc. (NBSE:NASDAQ), 53.38%
- Etao International Co. Ltd. (ETAO:NASDAQ), 50.6%